Edenor: Why The 75% Earnings Drop Is Misleading, And Metrogas Isn't Priced In Yet

Edenor’s Q2 2026 performance remains on a strong recovery path, with revenue up 10% YoY and EBITDA up 94% YoY (ex-CAMMESA). However, headline net earnings declined versus last year due to a non-recurring gain, tempering the headline story. The proposed $780M bid for Metrogas—if approved—could diversify operations and act as a medium-term growth catalyst, though integration risk keeps the setup balanced for an investor currently rated 'Hold.'

Analysis

EDN’s core story is no longer operating turnaround; it is now a valuation and capital-allocation question. Once a regulated utility’s earnings normalize, the market tends to stop rewarding headline growth and starts asking whether that cash flow is durable after inflation, FX, and policy leakage. That makes the stock vulnerable to multiple compression if investors conclude the current recovery is already embedded.

The Metrogas bid is the real swing factor, but the market should not assume synergies are immediately accretive. A regulated acquisition can improve scale and bargaining power, yet it also raises execution risk, financing pressure, and regulatory scrutiny; if funded with leverage, it may shift the equity story from earnings recovery to balance-sheet repair. The second-order implication is that any approval could help peer asset valuations in the Argentine utility space, but a rejection would remove the main medium-term catalyst and leave the shares exposed to a slow-growth, policy-driven rerating.

The consensus may be underestimating how quickly utility stocks can derate when the macro backdrop stops improving. Over the next 1-3 months, the key watch items are approval timing, funding terms, and whether management signals leverage discipline; over 6-18 months, the question is whether tariff normalization can outpace inflation and political interference. The thesis is falsified if the deal is blocked, net debt expands faster than EBITDA, or any tariff rollback interrupts cash conversion.

Key Decisions for Investors

• No fresh long at current levels; maintain EDN as a Hold and wait for either a 10-15% pullback or clearer deal financing before adding. Risk/reward is poor if the market is already discounting normalization.
• Relative-value idea: long EDN / short ARGT for the next 1-3 months if you want idiosyncratic upside to dominate Argentina beta. This works only if regulatory approval and financing terms come through without leverage surprise.
• For existing EDN holders, trim into strength ahead of the Metrogas decision rather than into the announcement. The upside from approval is likely smaller than the downside from a rejected or dilutive structure.
• Set a hard alert on post-deal leverage and tariff language: if net debt/EBITDA trends materially higher or pricing policy turns less constructive, exit the position. That would invalidate the medium-term bull case.